CLINICAL_TRIALS
trial_result
· 2014-01-10
Clinical Trial Update: Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization [Phase 4]
Summary
Phase 4 clinical trial update evaluating aflibercept intravitreal injections for myopic choroidal neovascularization.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto de Olhos de Goiania | Conditions: Choroidal Retinal Neovascularization | Phase 4 | Status: UNKNOWN